Catalent (CTLT) stock rises on reports of imminent $16.5 billion sale to Novo Holdings with FTC approval and EU Commission ...

Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...

By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.

Though M&A deal value and volume both declined in biopharma in 2024 compared to the year prior, PwC analysts still believe ...

A Sheffield-based aquaculture biotechnology company says it has been through a “transformational” year after selling one of its key divisions for £260m in an effort to simplify its business model.

Aquaculture biotechnology company, Benchmark, says it has performed resiliently “in a year of change and market headwinds”, ...

The presented poster is now available on the Reunion website at: https://reunionneuro.com/science/#publications.

On Tuesday, Spruce Biosciences Inc (SPRB) stock saw a modest uptick, ending the day at $0.54 which represents no change from the prior close of of $0.54. The stock opened at $0.55 and touched a low of ...

Richard J. Durbin (Illinois) and Benjamin L. Cardin (Maryland), sent Oz a letter asking whether he was qualified for the job ...

Pablo Mazo is the new CEO of Benchmark Genetics Salten after a period as acting CEO. Pablo Mazo has taken over as CEO of ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment ...